Randomized, blinded clinical study evaluating injectable autologous hair follicle secretome in patients with androgenic ...
Largest FDA-authorized Phase 2 cell therapy trial conducted in chronic lumbar disc diseaseThe study has enrolled a total of ...
Research indicates that many statin therapy side effects are not supported by evidence, suggesting a need for revised ...
SALT LAKE CITY, February 11, 2026--iVeena Delivery Systems, Inc. ("iVeena"), a clinical-stage ophthalmology company developing novel pharmacologic therapies for refractive eye diseases, today ...
Rapid Medical™, a leading developer of active endovascular devices, today announced late-breaking results from the DISTALS multicenter, randomized controlled trial showing that TIGERTRIEVER™ 13 ...
CNW/ -- (CSE: INNO) (FSE: IP40) (OTCQB: INNPD) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and ...
Leading vaccine researchers say that the proposed vaccine trials could lead to unreliable conclusions on already-approved ...
Our findings indicate that a large commercial insurer is increasingly covering acupuncture for its beneficiaries. Unlike Medicare Part B, which limits acupuncture coverage to chronic low back pain, ...
A large-scale study finds that most listed statin side effects are minimal, while the cardiovascular benefits dominate, prompting calls to revise labeling for clearer decision-making.
FDA proposes MRD-negative and complete response endpoints to fast-track multiple myeloma drug approvals, pushing deeper molecular results over ORR.
A division of the U.S. Agency for International Development eliminated by Trump administration cuts last year was reborn ...
In combined analysis (n = 39), the average wound closure rate was 98%, and all 19 patients previously diagnosed for potential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results